Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$210.25
+1.1%
$195.05
$163.81
$218.66
$371.68B0.54.61 million shs4.26 million shs
International Business Machines Corporation stock logo
IBM
International Business Machines
$243.59
-0.9%
$265.72
$198.27
$296.16
$226.30B0.695.10 million shs2.97 million shs
Realty Income Corporation stock logo
O
Realty Income
$58.75
+1.1%
$57.64
$50.71
$64.88
$53.72B0.765.38 million shs4.37 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+1.13%-0.02%+10.85%+13.32%+7.54%
International Business Machines Corporation stock logo
IBM
International Business Machines
-0.90%+0.79%-6.37%-5.91%+22.74%
Realty Income Corporation stock logo
O
Realty Income
+1.12%-0.19%+3.42%+3.79%-5.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.7576 of 5 stars
2.54.03.33.93.32.51.9
International Business Machines Corporation stock logo
IBM
International Business Machines
4.925 of 5 stars
3.25.03.33.53.40.82.5
Realty Income Corporation stock logo
O
Realty Income
3.0387 of 5 stars
1.12.02.51.72.31.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.92
Moderate Buy$214.952.24% Upside
International Business Machines Corporation stock logo
IBM
International Business Machines
2.47
Hold$268.7510.33% Upside
Realty Income Corporation stock logo
O
Realty Income
2.25
Hold$62.005.53% Upside

Current Analyst Ratings Breakdown

Latest ABBV, IBM, and O Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2025
Realty Income Corporation stock logo
O
Realty Income
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$58.00 ➝ $60.00
8/25/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
8/20/2025
Realty Income Corporation stock logo
O
Realty Income
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$58.00 ➝ $59.00
8/15/2025
Realty Income Corporation stock logo
O
Realty Income
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$62.00 ➝ $66.00
8/14/2025
International Business Machines Corporation stock logo
IBM
International Business Machines
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
8/12/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$231.00
8/11/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/7/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Daiwa America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/7/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Daiwa Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$214.00
8/1/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$250.00 ➝ $255.00
8/1/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$216.00 ➝ $227.00
(Data available from 8/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B6.59$14.92 per share14.09($0.08) per share-2,628.14
International Business Machines Corporation stock logo
IBM
International Business Machines
$62.75B3.61$15.53 per share15.69$29.68 per share8.21
Realty Income Corporation stock logo
O
Realty Income
$5.27B10.19$3.81 per share15.42$43.05 per share1.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.10100.1215.041.356.45%699.66%13.64%10/29/2025 (Estimated)
International Business Machines Corporation stock logo
IBM
International Business Machines
$6.02B$6.1639.5421.003.759.11%37.62%7.08%10/22/2025 (Estimated)
Realty Income Corporation stock logo
O
Realty Income
$860.77M$1.0357.0413.604.4916.77%2.34%1.32%11/3/2025 (Estimated)

Latest ABBV, IBM, and O Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Realty Income Corporation stock logo
O
Realty Income
$1.06$1.05-$0.01$1.05$1.33 billion$1.34 billion
7/31/2025Q2 2025
AbbVie Inc. stock logo
ABBV
AbbVie
$3.24$2.97-$0.27$0.52$14.93 billion$15.42 billion
7/23/2025Q2 2025
International Business Machines Corporation stock logo
IBM
International Business Machines
$2.65$2.80+$0.15$2.31$16.58 billion$16.98 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.563.12%N/A312.38%53 Years
International Business Machines Corporation stock logo
IBM
International Business Machines
$6.722.76%N/A109.09%30 Years
Realty Income Corporation stock logo
O
Realty Income
$3.235.50%N/A313.59%1 Years

Latest ABBV, IBM, and O Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/14/2025
Realty Income Corporation stock logo
O
Realty Income
monthly$0.26905.5%9/2/20259/2/20259/15/2025
7/23/2025
International Business Machines Corporation stock logo
IBM
International Business Machines
Quarterly$1.682.78%8/8/20258/8/20259/10/2025
6/20/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.643.54%7/15/20257/15/20258/15/2025
7/8/2025
Realty Income Corporation stock logo
O
Realty Income
aug 25$0.26905.7%8/1/20258/1/20258/15/2025
6/10/2025
Realty Income Corporation stock logo
O
Realty Income
jul 25$0.26905.6%7/1/20257/1/20257/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
44.14
0.74
0.61
International Business Machines Corporation stock logo
IBM
International Business Machines
2.00
0.91
0.87
Realty Income Corporation stock logo
O
Realty Income
0.72
1.85
1.85

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
International Business Machines Corporation stock logo
IBM
International Business Machines
58.96%
Realty Income Corporation stock logo
O
Realty Income
70.81%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
International Business Machines Corporation stock logo
IBM
International Business Machines
0.18%
Realty Income Corporation stock logo
O
Realty Income
0.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
55,0001.77 billion1.76 billionOptionable
International Business Machines Corporation stock logo
IBM
International Business Machines
293,400929.40 million927.72 millionOptionable
Realty Income Corporation stock logo
O
Realty Income
400914.31 million913.39 millionOptionable

Recent News About These Companies

Realty Income: King Of REITs Still Offers Viable Monthly Incomes
The 5 Best Dividend Stocks to Buy Now
3 Best Dividend Stocks to Buy Now
Realty Income (NYSE:O) Shares Down 1.1% - Should You Sell?
Realty Income Q2 Results: The Good And The Bad

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$210.25 +2.33 (+1.12%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$212.08 +1.83 (+0.87%)
As of 08/29/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

International Business Machines stock logo

International Business Machines NYSE:IBM

$243.59 -2.14 (-0.87%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$243.12 -0.47 (-0.19%)
As of 08/29/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.

Realty Income stock logo

Realty Income NYSE:O

$58.75 +0.62 (+1.07%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$58.70 -0.05 (-0.08%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O).